Clinical trial
Efficacy of Inhaled Nitric Oxide in Congenital Diaphragmatic Hernia With Early Pulmonary Hypertension
NCT07247240 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of Inhaled Nitric Oxide in Congenital Diaphragmatic Hernia With Early Pulmonary Hypertension
- Lead sponsor
- Asan Medical Center
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- November 30, 2025
- Completion date
- December 31, 2028
- Enrollment
- 40 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
congenital diaphragmatic hernia, pulmonary hypertension